(Q33485906)

27 July 2017

title

Application of screening methods, shape signatures and engineered biosensors in early drug discovery process (English)

1 reference

27 July 2017

0 references

1 reference

Izabela Hartman

1

1 reference

27 July 2017

Alison R Gillies

2

1 reference

27 July 2017

Sonia Arora

3

1 reference

27 July 2017

Christina Andaya

4

1 reference

27 July 2017

Nitya Royapet

5

1 reference

27 July 2017

William J Welsh

6

1 reference

27 July 2017

David W Wood

7

1 reference

27 July 2017

Randy J Zauhar

8

1 reference

27 July 2017

publication date

22 July 2009

1 reference

27 July 2017

published in

Pharmaceutical Research

1 reference

27 July 2017

volume

26

1 reference

27 July 2017

issue

10

1 reference

27 July 2017

page(s)

2247-2258

1 reference

Docking of phosphonate and trehalose analog inhibitors into M. tuberculosis mycolyltransferase Ag85C: Comparison of the two scoring fitness functions GoldScore and ChemScore, in the GOLD software

27 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-009-9941-Z

Engineered chimeric enzymes as tools for drug discovery: generating reliable bacterial screens for the detection, discovery, and assessment of estrogen receptor modulators.

21 January 2018

1 reference

12 December 2020

EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and beta

1 reference

12 December 2020

The Protein Data Bank

1 reference

12 December 2020

Structure-based design of estrogen receptor-beta selective ligands

1 reference

12 December 2020

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

1 reference

12 December 2020

ZINC--a free database of commercially available compounds for virtual screening

1 reference

12 December 2020

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

12 December 2020

Shape Signatures: speeding up computer aided drug discovery

1 reference

12 December 2020

Development and validation of a genetic algorithm for flexible docking

1 reference

12 December 2020

Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen

1 reference

12 December 2020

A bacterial biosensor of endocrine modulators

1 reference

12 December 2020

Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens

1 reference

12 December 2020

Enrichment of ligands for the serotonin receptor using the Shape Signatures approach

1 reference

12 December 2020

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

12 December 2020

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a "divide and conquer" strategy

1 reference

12 December 2020

Molecular determinants of tissue selectivity in estrogen receptor modulators

1 reference

12 December 2020

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

12 December 2020

Silencing and reactivation of the selective estrogen receptor modulator-estrogen receptor alpha complex.

1 reference

12 December 2020

Rapid detection of subtype-selective nuclear hormone receptor binding with bacterial genetic selection

1 reference

12 December 2020

Flexible docking using Tabu search and an empirical estimate of binding affinity.

1 reference

12 December 2020

Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design

1 reference

12 December 2020

Improved protein-ligand docking using GOLD

1 reference

12 December 2020

Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach

1 reference

12 December 2020

The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer.

1 reference

12 December 2020

Characterization of molecular and structural determinants of selective estrogen receptor downregulators

1 reference

12 December 2020

The estrogen receptor: a model for molecular medicine.

1 reference

12 December 2020

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

1 reference

12 December 2020

(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen

1 reference

12 December 2020

Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism

1 reference

12 December 2020

A new test set for validating predictions of protein-ligand interaction.

1 reference

12 December 2020

10.1007/S11095-009-9941-Z

Identifiers

DOI

1 reference

27 July 2017

1 reference